97 related articles for article (PubMed ID: 8824562)
1. Inhibitors of anchorage-independent growth affect the growth of transformed cells on poly(2-hydroxyethyl methacrylate)-coated surfaces.
Fukazawa H; Nakano S; Mizuno S; Uehara Y
Int J Cancer; 1996 Sep; 67(6):876-82. PubMed ID: 8824562
[TBL] [Abstract][Full Text] [Related]
2. Direct tumorigenic conversion of human gallbladder carcinoma cells by v-src but not by activated c-H-ras oncogene.
Tatsumoto T; Nakano S; Shimizu K; Ono M; Esaki T; Ohshima K; Niho Y
Int J Cancer; 1995 Apr; 61(2):206-13. PubMed ID: 7705949
[TBL] [Abstract][Full Text] [Related]
3. Morphology of ras-transformed cells becomes apparently normal again with tyrosine kinase inhibitors without a decrease in the ras-GTP complex.
Kwon HJ; Yoshida M; Muroya K; Hattori S; Nishida E; Fukui Y; Beppu T; Horinouchi S
J Biochem; 1995 Jul; 118(1):221-8. PubMed ID: 8537316
[TBL] [Abstract][Full Text] [Related]
4. A microplate assay for quantitation of anchorage-independent growth of transformed cells.
Fukazawa H; Mizuno S; Uehara Y
Anal Biochem; 1995 Jun; 228(1):83-90. PubMed ID: 8572292
[TBL] [Abstract][Full Text] [Related]
5. v-src induces cisplatin resistance by increasing the repair of cisplatin-DNA interstrand cross-links in human gallbladder adenocarcinoma cells.
Masumoto N; Nakano S; Fujishima H; Kohno K; Niho Y
Int J Cancer; 1999 Mar; 80(5):731-7. PubMed ID: 10048975
[TBL] [Abstract][Full Text] [Related]
6. Suppression of malignant growth potentials of v-Src-transformed human gallbladder epithelial cells by adenovirus-mediated dominant negative H-Ras.
Tokumitsu Y; Nakano S; Ueno H; Niho Y
J Cell Physiol; 2000 May; 183(2):221-7. PubMed ID: 10737897
[TBL] [Abstract][Full Text] [Related]
7. [Protein kinase inhibitors--screening of new molecular target therapeutics].
Uehara Y
Gan To Kagaku Ryoho; 1997 Jan; 24(2):136-44. PubMed ID: 9030224
[TBL] [Abstract][Full Text] [Related]
8. Radicicol inhibits tyrosine phosphorylation of the mitotic Src substrate Sam68 and retards subsequent exit from mitosis of Src-transformed cells.
Pillay I; Nakano H; Sharma SV
Cell Growth Differ; 1996 Nov; 7(11):1487-99. PubMed ID: 8930398
[TBL] [Abstract][Full Text] [Related]
9. KF25706, a novel oxime derivative of radicicol, exhibits in vivo antitumor activity via selective depletion of Hsp90 binding signaling molecules.
Soga S; Neckers LM; Schulte TW; Shiotsu Y; Akasaka K; Narumi H; Agatsuma T; Ikuina Y; Murakata C; Tamaoki T; Akinaga S
Cancer Res; 1999 Jun; 59(12):2931-8. PubMed ID: 10383157
[TBL] [Abstract][Full Text] [Related]
10. Src tyrosine kinase but not activated Ras augments sensitivity to taxanes through apoptosis in human adenocarcinoma cells.
Boudny V; Nakano S
Anticancer Res; 2003; 23(1A):7-12. PubMed ID: 12680188
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of anchorage-independent growth of ras-transformed cells on polyHEMA surface by antisense oligodeoxynucleotides directed against K-ras.
Kawada M; Fukazawa H; Mizuno S; Uehara Y
Biochem Biophys Res Commun; 1997 Feb; 231(3):735-7. PubMed ID: 9070883
[TBL] [Abstract][Full Text] [Related]
12. Interferon-alpha and -gamma inhibit the growth and neoplastic potential of v-src-transformed human epithelial cells by reducing Src tyrosine kinase activity.
Fujishima H; Nakano S; Tatsumoto T; Masumoto N; Niho Y
Int J Cancer; 1998 May; 76(3):423-9. PubMed ID: 9579582
[TBL] [Abstract][Full Text] [Related]
13. Effects of tyrosine kinase inhibitors on the proliferation of human breast cancer cell lines and proteins important in the ras signaling pathway.
Clark JW; Santos-Moore A; Stevenson LE; Frackelton AR
Int J Cancer; 1996 Jan; 65(2):186-91. PubMed ID: 8567115
[TBL] [Abstract][Full Text] [Related]
14. Reversal of transformed phenotypes by herbimycin A in src oncogene expressed rat fibroblasts.
Murakami Y; Mizuno S; Hori M; Uehara Y
Cancer Res; 1988 Mar; 48(6):1587-90. PubMed ID: 3345529
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of protein kinase inhibitors in an assay system containing multiple protein kinase activities.
Li PM; Fukazawa H; Mizuno S; Uehara Y
Anticancer Res; 1993; 13(6A):1957-64. PubMed ID: 8297101
[TBL] [Abstract][Full Text] [Related]
16. Benzoquinonoid ansamycins possess selective tumoricidal activity unrelated to src kinase inhibition.
Whitesell L; Shifrin SD; Schwab G; Neckers LM
Cancer Res; 1992 Apr; 52(7):1721-8. PubMed ID: 1551101
[TBL] [Abstract][Full Text] [Related]
17. Evidence that c-src is involved in the process of osteoclastic bone resorption.
Hall TJ; Schaeublin M; Missbach M
Biochem Biophys Res Commun; 1994 Mar; 199(3):1237-44. PubMed ID: 8147865
[TBL] [Abstract][Full Text] [Related]
18. Effect of herbimycin A on growth and pp60c-src activity in human colon tumor cell lines.
Garcia R; Parikh NU; Saya H; Gallick GE
Oncogene; 1991 Nov; 6(11):1983-9. PubMed ID: 1719464
[TBL] [Abstract][Full Text] [Related]
19. Induction by herbimycin A of contact inhibition in v-src-expressed cells.
Suzukake-Tsuchiya K; Moriya Y; Hori M; Uehara Y; Takeuchi T
J Antibiot (Tokyo); 1989 Dec; 42(12):1831-7. PubMed ID: 2559910
[TBL] [Abstract][Full Text] [Related]
20. Targeting of the protein chaperone, HSP90, by the transformation suppressing agent, radicicol.
Sharma SV; Agatsuma T; Nakano H
Oncogene; 1998 May; 16(20):2639-45. PubMed ID: 9632140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]